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ABSTRACT
Cdc28 is the main cyclin-dependent kinase (CDK) directing the yeast cell cycle. Besides cyclin
binding, Cdc28 requires phosphorylation by Cak1 (CDK-activating kinase) to achieve full activity.
In previous work, our laboratory isolated carboxy-terminal cdc28CST mutants that display high
temperature sensitivity and chromosome instability. These phenotypes are suppressed by increasing
the copy numbers of Cak1 in its catalytically active or inactive form. The cdc28CST mutants are also
extremely sensitive to changes in Cak1 integrity and dosage. These results indicated that besides
the activating phosphorylation by Cak1, the interaction between Cak1 and the carboxyl terminus of
Cdc28 is important to maintain stable and active Cdc28 complexes. In this thesis, I discuss recent
results that suggest that Cdc28 is highly dependent on Cak1 levels, even in wild type cells. Because
actively growing cells require cycles of high CDK activity, we hypothesize that this can be
achieved only by maintaining an optimum Cdc28:Cak1 ratio. We found that alteration of this ratio
by increasing Cdc28 copy numbers is deleterious, but this effect is suppressed by concomitant
increase of the copy numbers of Cak1 (catalytically active or inactive). We found that there is a
very good correlation between active cell growth and Cak1 levels. Based on these results we
propose the following model: When cells sense depletion of nutrients and must cease dividing,
Cak1 is degraded to alter the Cdc28:Cak1 ratio leading to quick inactivation of Cdc28. According
to this model, Cak1 functions as an assembly factor for Cdc28 CDK complexes coordinating
nutrient availability and cell growth in yeast.
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CHAPTER I - Introduction
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Regulation of Cyclin-Dependent Kinases

Cyclin-dependent kinases (CDKs) are the main cell cycle regulators in all eukaryotes. Only one
CDK, Cdc28, is necessary for cell cycle progression in the budding yeast Saccharomyces cerevisiae
(Fig. 1). Activation of Cdc28 requires association with the Cks1/Suc1 subunit (16) and one of nine
different cyclins, and phosphorylation of Thr169 in the T-loop (30). Negative regulation is provided
by the binding of inhibitors and phosphorylation at the amino-terminal lobe by the Swe1 kinase (29).
Cdc28 is expressed constitutively throughout the cell cycle but its activity is regulated by the identity
of the bound cyclin subunit: Cyclins Cln1-3 promote progression through G1, and B-type cyclins
(Clb 1-6) activate S-phase and mitosis. The abundance of these cyclins is regulated via
transcriptional and ubiquitin-dependent proteolysis (2, 30).

CDKs are highly conserved enzymes at both the structural and functional levels. For example,
human Cdk1 and Cdk2 are 60 – 65% identical to fission yeast Cdc2 and budding yeast Cdc28 (10).
In 1996, Russo et al. revealed the mechanism of CDK activation via analysis of the crystal structure
of the Cdk2-cyclin A complex (34). After binding with cyclin A, Cdk2 activity is partially increased.
Cyclin A binding induces conformational changes in the Cdk2 active site that leads to exposure of
Thr160 in the activation loop (Thr169 in Cdc28), allowing its phosphorylation by the CDKactivating kinase CAK. This phosphorylation induces additional 80-300 fold activation (30) by
promoting more Cdk2-Cyclin A contacts that stabilize the complex and also affects substrate binding
(Fig. 2) (33).

Classes of CDK-activating kinases CAK

2

Bud emergence
SPB duplication

G1
DNA replication

S

G2
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Spindle elongation

Onset of anaphase
Sister chromatids separation

Fig. 1. Cdc28 is the main cyclin-dependent kinase (CDK) regulating the cell cycle in yeast. To
promote cell-cycle progression, Cdc28 associates with a particular cyclin (Cln1-3 or Clb1-6) that
confers substrate specificity and localization cues to the complex. To allow cells to exit from mitosis,
Cdc28 is inactivated mainly via degradation of the mitotic cyclin Clb2.
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Fig. 2. Structural model of a CDK-cyclin complex. The CDK subunit is shown in blue, the cyclin
subunit in gray, and the Cks1/Suc1 activator in dark yellow. The residue phosphorylated by the CAK
enzymes is indicated by the green star (Thr169 in Cdc28), and the activation or T-loop is shown in
green. The binding sites of ATP and the peptide substrate are also indicated. The PSTAIRE helix
(red) is present in most CDKs and functions in cyclin binding (34).
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There are two classes of CAKs: monomeric Cak1 from budding yeast and the trimeric complex
(Cdk7/cyclin H/MAT1) from vertebrates. CDK activation via phosphorylation by CAKs has two
alternative pathways: Cdk7/cyclin H/MAT1 phosphorylates CDKs that are already associated with
cyclins, and Cak1 phosphorylates monomeric Cdc28. These two CAKs also have different
localizations and roles. Cdk7/cyclin H/MAT1 localizes to the nucleus but Cak1 localizes mainly in
the cytoplasm (22). The trimeric CAK is also involved in transcription as part of the transcription
factor II-H complex, which phosphorylates the C-terminal domain (CTD) of the large subunit of
RNA polymerase II. In S. cerevisiae, Kin28 is the most similar to Cdk7 with 47% identity and the
binding partner of Kin28 is Ccl1, which is related to cyclin H. Like the trimeric CAK, Kin28 and
Ccl1 are subunits of the transcription factor II-H complex and Kin28 is the CTD kinase, but it does
not possess CAK activity (6).
Besides S. cerevisiae’s Cak1, other momoneric CAK activities have been reported in S. pombe
(Csk1), C. albicans (Cak1), and A. thaliana (Cak1At). Interestingly, these monomeric enzymes share
several properties: All these monomeric CAKs phosphorylate cyclin-free CDKs, as does Cak1 in
budding yeast (40).

Cak1 is an unusual kinase and has various functions

Most protein kinases have a glycine loop characterized by the motif GXGXXG (where X is any
amino acid), located near the amino terminus of the kinase domain (Fig. 3). The glycine residues
provide flexibility and help the loop to fold over the nucleotide, thereby stabilizing the ATP molecule.
In 1996, Solomon and colleagues compared the amino acid sequences of Cak1 with other kinases,
finding that Cak1 lacks a glycine loop.

5

Fig. 3. Sequence comparison of Cak1 with Cdk7 (human [hs]), Kin28 (S. cerevisiae [sc]), and
Csk1 (S. pombe [sp]). The GXGXXG motif is indicated in red. The invariant lysine residue is
indicated in green. Residue Asp179 (shown in orange) is critical for magnesium binding and its
mutation abolishes catalytic activity (cak1-KD). Mutation of residue Asp226 (in blue) to Ala causes
temperature sensitivity in yeast (cak1-23). The residues shown in a black background are present in
all four kinases, and the ones in gray are present in three or two of the sequences.
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Cak1 also contains non-conservative replacements at 4 of 15 highly conserved amino acid
positions in protein kinases. Interestingly, Cak1 is not affected by either mutation or deletion of this
region (11). Another highly conserved feature of protein kinases is the invariant lysine residue,
located carboxy-terminal to the glycine loop within the ATP-binding pocket (Lys31 in Cak1). This
residue is required for activity, and interacts with the α- and β- phosphates of ATP to ensure proper
alignment of the triphosphate chain. In contrast, Cak1 functions even with a truncation of its first 31
amino acids, including the glycine loop and Lys31(5, 17). Therefore, Cak1’s nucleotide-binding
pocket differs significantly from that of most other kinases and its identification remains pending.

Cak1 has various functions. Besides phosphorylating Cdc28, Cak1 is involved in spore wall
morphogenesis (41), and phosphorylation of the Kin28, Bur1, and Ctk1 CDKs that regulate
transcription as CTD-kinases. Cak1 also interacts functionally with Paf1 and Ctr9, the two
components of the PAF1 elongation complex required for histone modifications, and with the protein
phosphatase Ssu72 via Ctk1 and Bur1 (14). However, Cak1 is only essential for phosphorylating
Cdc28 (39), as demonstrated by the isolation of cdc28 mutants harboring several substitutions
including Thr169Glu that remain viable in the absence of Cak1 (7, 8).

Mutagenesis of the carboxyl terminus of Cdc28

In wild type cells, treatment with microtubule toxins such as benomyl or nocodazole, or presence
of non-functional kinetochores leads to activation of the spindle assembly checkpoint (1).
Kinetochores are large protein complexes that assemble at centromeric regions and serve as the site
of attachment for the spindle microtubules. Accordingly, their correct function is critical to facilitate
separation and segregation of the duplicated chromosomes (43). The role of the spindle assembly
7

checkpoint is to prevent spontaneous chromosome loss by coordinating the assembly and
disassembly of the mitotic apparatus, and the timing of separation of the duplicated chromosomes
(27). Our laboratory has previously established a role for CDKs in spindle assembly checkpoint
regulation via the isolation of cdc28 mutants that are defective in the checkpoint response (24, 25).
These mutants show chromosome instability and enhanced benomyl sensitivity similar to checkpoint
mutants. Residues Arg287 and Arg288 in the carboxyl terminus of Cdc28 were substituted in some
of the mutants, which led our attention to the region. Introduction of more substitutions at the
carboxyl terminus of Cdc28 led to stronger phenotypes (cdc28-CIN1: Arg287Ser, His292Glu,
Pro293Leu, Tyr294Ile, Phe295Stop) (24). These data suggest a critical role for the carboxyl terminus
of Cdc28 that may contribute to the checkpoint response. Furthermore, while sequence alignments of
several CDKs show that their carboxyl termini are highly conserved (Fig. 4) (25), a specific function
has not been reported for this region.
To further investigate the role of the carboxyl terminus of Cdc28 in maintaining chromosome
stability, we searched for mutations in Cdc28 that enhance the temperature sensitivity of the
kinetochore mutant ctf13-30 (32) (see Table 1 for a description of all mutants used in these studies).
The reasoning behind this screen was that cells harboring defective kinetochores rely for viability on
pathways that prevent progression through mitosis (such as the spindle assembly checkpoint). If a
component of one such pathway were non-functional, the ctf13-30 mutant cells would progress
through mitosis with lethal consequences.

Fig. 4. The carboxyl termini of CDKs are highly conserved. Cdc28 is from S. cerevisiae, Cdk1,
Cdk2, Cdk4 and Cdk6 are human CDKs, and Cdc2 is from S. pombe (25).
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Table 1. Mutants used in this study

Name
cdc28-cst8

Definition
High chromosome instability, sensitive to high temperatures and

Reference
(25)

microtubule inhibitors (Ala290Gly His292Leu Pro293Ala
Gln296Ser)
cdc28-cst2

High chromosome instability, sensitive to high temperatures and

(25)

microtubule inhibitors (Ala290Gly Ile292Lys Pro293Ser
Tyr294Ser Ser298Pro)
mad1

Spindle checkpoint component, high sensitivity to microtubule

(18, 38)

inhibitors (mad1-181 allele, mutation unknown)
mad2

Spindle checkpoint component, high sensitivity to microtubule

(24)

inhibitors (deletion)
cdc28-T169A

Inactive, lethal, unphosphorylatable by Cak1 (Thr169Ala)

(23)

ctf13-30

Kinetochore component. Temperature sensitive and high

(9, 32)

chromosome loss (Lys146Glu)
cak1-KD

Catalytically inactive, mutation in magnesium binding site

(5)

(Asp179Asn)
cak1-23

Cak1 temperature sensitive mutant allele (Asp226Asn)

9

(12)

For the screen, codons 282, and 287 through 298 in CDC28 were randomly mutated via PCR (shown
in boldface in Fig. 4). Six mutants were isolated that bypass the mitotic arrest yielding unbudded
cells, multiply-budded cells, and cells that appear anucleate (25). These mutants show high rates of
chromosome loss therefore, we called this mutant cdc28CST (defective in maintenance of
chromosome stability). Sequence analysis showed multiple mutations, ranging from 4 to 7 of the 13
carboxy-terminal residues, particularly in residues Ile291 and Pro293 (Fig. 5) (25). Based on the
human Cdk2 structure, the mutated residues in the cdc28CST mutants localize to the solvent-accessible
surface but distant from the binding sites of ATP, substrate peptide, cyclin and Cks1 (4, 33, 37).

cdc28CST mutants exhibit microtubule inhibitor sensitivity

The cdc28CST mutants show temperature sensitivity forming only microcolonies at high
temperatures, and at 25°C, the cells are slightly larger than those of wild type. On the other hand,
when treated with benomyl, wild type cells arrest in mitosis and as they recover and/or the effect of
the drug diminishes, most cells are able to divide slowly and form colonies. Spindle assemblycheckpoint mutants fail to arrest and enter anaphase with incomplete spindles, causing chromosome
missegregation and cell death (26). As expected, the cdc28CST mutants are sensitive to benomyl to
levels comparable to those of the checkpoint mutants mad1 and mad2 (27) (Fig. 6).

High copy numbers of Cak1 suppress the temperature sensitivity of the cdc28CST mutants
independently of Cak1’s catalytic activity.

We hypothesized that the temperature sensitivity of the cdc28CST mutants might derive from
impaired interaction with a regulator. To attempt identification of this regulator(s), we performed
10

Fig. 5. Carboxy-terminal cdc28CST mutants harbor multiple substitutions. The diagram shows
the CDC28 chromosomal locus with the residues altered in the isolated mutants. Also shown is the
insertion site of the marker His3MX6, which allowed selection of the transformants (25).
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25 °C

32 °C

Benomyl

Wild type
cdc28-cst2
cdc28-cst8
mad1
mad2
Fig. 6. Carboxy-terminal cdc28 mutants are sensitive to the microtubule inhibitor benomyl and
high temperatures. Wild type and mutant strains were serially diluted and aliquots from each
dilution were spotted on three different plates containing rich media only, or supplemented with the
microtubule inhibitor benomyl (12.5 µg/ml). Mad1 and Mad2 are two main components of the
spindle assembly checkpoint and in their absence, cells become “mitotic-arrest deficient” and
sensitive to benomyl. The plates were incubated for 2 – 3 days at the temperatures indicated in the
figure. The plate containing benomyl was incubated at 25 °C (25).
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a dosage suppression screen based on the temperature sensitivity of the mutants. cdc28-cst2 and
cdc28-cst3 strains were transformed with a high copy plasmid genomic library and analyzed for
enhanced thermoresistance. Several plasmids harboring CAK1 were found to suppress the
temperature sensitivity of both cdc28CST mutants.

Chun and Goebl described and characterized several cak1 point mutants. One of the mutations in
the residue responsible for coordinating a magnesium ion at the active site, Asp179Asn (Fig. 3),
caused Cak1 to be catalytically inactive (Cak1-KD) (5). We used this mutation to test whether
Cak1’s catalytic activity is essential for the suppression of the cdc28cst mutants. Besides the wild type
and the cdc28CST strains, we also used a temperature sensitive cak1-23 mutant as a control
(Asp226Ala, Fig. 3). The strains were transformed with high copy plasmids harboring CAK1 or
cak1-KD. Interestingly, we found that overexpression of cak1-KD suppressed all of the cdc28CST
mutants and as expected, did not complement cak1-23 (Fig. 7) (25). Based on these preliminary data,
we concluded that Cak1’s role regulating Cdc28 function not only involves phosphorylation of
Thr169, but also binding to its carboxyl terminus (Fig. 8).

In this thesis, I describe recent results that suggest that maintaining an optimum Cdc28:Cak1 ratio
is crucial in actively growing cells. Alteration of this ratio by increasing the copy number of the
CDC28 gene by one or two causes slow growth in wild type cells. This defect is suppressed by
concomitant increase of the copy numbers of Cak1 (catalytically active or inactive), indicating that
Cdc28 depends on Cak1 binding to remain active and stable. These data suggest that one mechanism
by which yeast cells regulate their division rates is by allowing presence of high Cak1 levels only
when high CDK activity is required. Supporting this model, we have also found that only actively
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25 °C
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Insert in plasmid

25 °C

35 °C

—
CAK1
cak1-KD
Wild type

25 °C

cak1-23

32 °C

25 °C

32 °C
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cak1-KD
cdc28-cst8

cdc28-cst2

Fig. 7. High copy numbers of catalytically active or inactive CAK1 suppress the temperature
sensitivity of the cdc28CST mutants. The panels show wild type, and temperature sensitive cak1 and
cdc28CSTmutants transformed with empty high copy plasmid control (“—”), and plasmids harboring
wild type CAK1 or the catalytically inactive allele cak1-KD (kinase dead). Cultures of similar
densities were serially diluted, aliquots spotted, and plates incubated at the indicated temperatures
(25).
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(a)

(b)
Clb2

Clb2
Cdc28*

Cak1 Cdc28
Cks1

Cks1

Fig. 8. Preliminary model. (a) Cak1 binds to the carboxyl terminus of Cdc28 functioning as an
assembly factor that stabilizes the CDK complexes to ensure presence of high kinase activity. (b)
Inability of Cak1 to bind to Cdc28 because of mutations in Cdc28 results in unstable complexes and
overall low CDK activity.
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growing cells display high Cak1 protein levels, and that these levels dramatically decrease as
nutrients are depleted and cells cease dividing.

16

CHAPTER II-Materials and methods
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Plasmids and yeast strains

All procedures use cells of the W303 genetic background. Plasmids harboring cdc28-T169A and
the cak1-23 strain were gifts from M. Solomon (Yale University) (23). pGAL1>GST-CAK1, CAK1
and cak1-KD plasmids were provided by K. Chun and M. Goebl (Indiana University) (5). We use the
“>” symbol to indicate the promoter that controls expression of a gene or fusion.
Analysis of the effect of altering copy numbers was performed using high or low copy plasmid
vectors. High copy plasmids are derived from the endogenous 2µ plasmid, which can accumulate up
to ~60 – 100 copies per cell. Low copy plasmids harbor centromeres (CEN) that allow tight
segregation during cell division and are usually present in 1 – 2 copies per cell (36).
Plasmids pGAL1>CDC28, pGALS>CDC28, and pGAL1>CAK1 (without epitope tags) were
constructed by amplifying the respective sequences using pFA6a-kanMX6-pGAL1 and genomic
DNA as templates. The flanking restriction sites were designed as SalI and BamHI. To make the
pGAL1>CDC28 and pGALS>CDC28 constructs, the GAL1 and GALS promoter regions were
amplified using the SAL1GAL1FW and SAL1GALSFW primers respectively, and the CDC28RV
primer. The CDC28 open reading frame (ORF) was amplified using primers CDC28FW and
CDC28BamHI. These two polymerase chain reaction (PCR) fragments were then fused together via
their overlapping 25 bp ends using the outer most forward and reverse primers. The final fusion-PCR
products were cloned into pRS315 (CEN LEU2, CDC28 plasmids).
A similar strategy was used to construct the pGAL1>CAK1 and pGALS>CAK1 plasmids. The GAL1
or GALS promoter region was amplified using the SAL1GAL1FW or SAL1GALS, and the CAK1RV
primers. The CAK1 ORF was amplified using CAK1FW and CAK1BamHI primers. The final fusionPCR products were cloned into pRS316 (CEN URA3, CAK1 plasmids).
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Determination of transformation efficiencies

Wild type, cdc28-cst2, and cdc28-cst8 cells were first transformed with pRS202 (2µ URA3)
plasmids harboring no insert, CAK1, or cak1-KD. Single colonies were obtained on glucose plates
lacking uracil, grown in selective media, and normalized by measuring OD600nm. Using suspensions
of identical cell densities, a second transformation was performed with CEN TRP1 plasmids
harboring CDC28-HA or cdc28-T169A-HA, using the same amounts of DNA. After the final
transformation, cells were briefly sonicated to disrupt aggregates. Numbers of cells were determined
by manual counting using a hemacytometer. After normalization of cell densities, suspensions were
serially diluted 5-fold with water and spotted onto media lacking uracil or both uracil and tryptophan.
Plates were incubated for 2 to 4 days at 25 °C.

Effects of overexpressing CDC28 and cak1-KD in wild type and the cak1-23 mutant

Wild type and cak1-23 mutant strains (12) were co-transformed with a low copy CEN LEU2
plasmid harboring no insert ("—") or GALS>CDC28, and a high copy URA3 plasmid harboring no
insert ("—") or cak1-KD. After transformations, single colonies from each of the combinations were
grown on glucose plates lacking both leucine and uracil to select for presence of both plasmids.
These cultures were then grown in similar selective media containing 2% raffinose for 3 - 4 days at
25 °C until saturation, to ensure similar cell densities. Cultures in raffinose allowed derepression of
the GAL promoter. Saturated cultures were serially diluted (3 fold), and spotted onto plates lacking
uracil and leucine and containing either glucose (GAL promoters OFF), or 2% galactose and 2%
raffinose (GAL promoters ON). The plates were incubated at 25 and 30 °C for 2-3 days.
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cak1-KD was overexpressed in cak1-23 and wild type cells. Cells were co-transformed with high
copy URA3 plasmid harboring empty vector and low copy CEN LEU2 plasmid harboring
GAL1>cak1-KD using the same strategy as above. The plates were incubated at 25 and 32 °C for 2 3 days.

Protein extract preparations and Western blotting

To examine Cak1 protein levels as cells grow and nutrients become limited, wild type cells
expressing a GST-Cak1 fusion under the control of the GAL1 promoter were grown in media
containing 2% raffinose. Cells were diluted, treated with 2% galactose and aliquots collected in a
time course for 34 hours. Cells were centrifuged and the pellets washed twice with 1X PBS 10%
glycerol (PBSgly), and kept at -80 °C until use. Cells were disrupted in PBSgly containing 1mM
phenylmethane sulfonylfluoride and 1x protease inhibitor cocktail (Roche) by vortexing with glass
beads for 10 min at 4 °C. Suspensions were then centrifuged for 30 min at 4 °C to obtain the clear
supernatant. Protein concentrations were determined using the Bradford method (ADV01 reagent
from Cytoskeleton Inc). Aliquots containing 100 µg proteins were separated in 12% SDS-PAGE gels.
Two strategies were implemented to avoid non-specific proteolysis of Cak1 during sample
processing: Use of a strain lacking vacuolar proteases due to deletion of the pep4 gene, and
preparation of the protein extracts under denaturing conditions (13). pep4::kanMX6 cells were
transformed with pGAL>GST-CAK1, or empty pEG(KG)His vector expressing only GST as control.
Cells were grown in 2% raffinose containing media, diluted, and treated in 2% galactose. Aliquots
were collected at 3 hour intervals for 24 hours. Frozen pellets were resuspended in 20%
trichloroacetic acid and vortexed with glass beads for 10 min. Pellets were collected by
centrifugation, washed with 90% acetone three times, mixed with sample buffer, briefly sonicated to
20

facilitate suspension, and boiled for 5 min. Aliquots containing 50 or 10 μg of proteins (GST-Cak1 or
GST expressing cells, respectively) were used for Western blotting.
In all cases after SDS-PAGE, the separated proteins were transferred to nitrocellulose membranes.
Equal loading was confirmed by staining the membranes using the MemCode kit from Pierce and/or
using an anti-Adh1 antibody (1:20000, Calbiochem). The MemCode kit allows reversible staining
proteins on membranes and according to the manufacturer, has a sensitivity of up to 25 ng. Cak1 was
detected using polyclonal anti-Cak1 antibodies (1:4000, provided by P. Kaldis, NCI), or a
monoclonal anti-GST antibody (1:5000, Novagen) when expressed as a GST fusion. Cdc28 was
detected using a polyclonal anti-PSTAIRE antibody (1:2500, Santa Cruz), which also recognizes the
Pho85 CDK (top band in shown blots). Horseradish peroxidase -conjugated goat anti-mouse IgG or
anti-rabbit IgG antibody and Super-Signal Substrate (Pierce) were used for detection.

21

CHAPTER III-Results
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The cdc28CST mutants are highly sensitive to changes in Cak1 integrity and dosage.

In previous studies, we found that increasing dosages of CAK1 suppress both the temperature
sensitivity and chromosome instability of the cdc28CST mutants (25). Since Cak1 and Cdc28 proteins
interact, a corollary of this hypothesis is that disrupting Cak1 function would have a deleterious
effect in the cdc28CST mutants. First, we tested for genetic interactions between the cdc28CST and
cak1 mutations (cak1-4, cak1-17 and cak1-23). Haploid cells harboring both mutations could not be
obtained, suggesting that a combination of cdc28CST and cak1 mutations results in inviable cells
(synthetic lethality). Furthermore, similar synthetic effects were observed when the chromosomal
copy of CAK1 was modified to express carboxy-terminal fusions with 13-Myc or 3-HA. Presence of
these epitope tags in an otherwise wild type cell caused only mild growth defects.

Interestingly, the cdc28CST mutants also loose viability when transformed with plasmids harboring
cdc28-T169A, an unphosphorylatable (thus inactive) allele in which Cak1's target residue Thr169 has
been substituted for Ala. For these studies, wild type and the cdc28CST mutant strains were
transformed with plasmids harboring no insert, wild type CDC28 or cdc28-T169A. These are
centromeric plasmids (1-2 copies per cell) and carry a TRP1 marker for selection. There was no
difference between wild type and cdc28CST mutants when transformed with empty vector or wild type
CDC28 plasmids; however, transformation efficiencies of the cdc28CST mutants significantly
decreased when transformed with cdc28-T169A (Fig. 9). These results suggest that
unphosphorylatable cdc28-T169A binds to and sequesters Cak1, thereby lowering its overall dosage
and causing a dominant negative effect only in the cdc28CST mutants. To examine if the deleterious
effect in the cdc28CST mutants expressing cdc28-T169A is due to titration of Cak1, the assay was
repeated in the presence of high copy numbers of CAK1 (Fig. 10).
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Vector

Vector

cdc28-T169A

cdc28-T169A

CDC28

CDC28

Wild type

cdc28-cst8

Fig. 9. Only cdc28CST mutants harboring the cdc28-T169A plasmid show reduced
transformation efficiency. Wild type and cdc28CST mutants were transformed under identical
conditions, with either empty vector or the same vector harboring wild-type CDC28 or the
unphosphorylatable allele cdc28-T169A. The transformation mixes were spread on medium lacking
tryptophan and the plates were incubated at 25 °C for 3-4 days.

24

Fig. 10. High-copy numbers of CAK1 or cak1-KD suppress the deleterious effects of a plasmid
harboring cdc28-T169A in the cdc28CST mutants. The mutants were first transformed with high
copy URA3 plasmids carrying no insert “—”, wild type CAK1, or cak1-KD. Single colonies of these
transformants were then grown in media lacking uracil, and subjected to a second transformation
with single copy TRP1 plasmids carrying either wild type CDC28 or the cdc28-T169A allele. The
cell densities in the transformation mixes were normalized and the obtained suspensions serially
diluted. Aliquots from each of the dilutions were then spotted on media lacking uracil or both uracil
and tryptophan. Pictures were taken after 2- 3 days incubation at 25 °C.
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First, the cdc28CST mutants were transformed with high copy URA3 plasmids carrying no insert, wild
type CAK1, or catalytically inactive cak1-KD. Selected transformants were then normalized and
subjected to a second transformation with the same amount of CEN TRP1 plasmid carrying either
wild type CDC28 or cdc28-T169A. The final transformation mixes were normalized for cell densities
and serially diluted 5-fold. Cells were spotted on media lacking uracil ("-U") or both uracil and
tryptophan ("-UW"). Plates were incubated at 25 °C for 2 - 3 days. Similar growth on the -U plates
confirmed that equal numbers of cells were spotted. On the -UW plates, we examined the
transformation efficiencies for the CDC28 and cdc28-T169A plasmids. High copy numbers of either
CAK1 or cak1-KD increased the transformation efficiencies in the cdc28CST strain ~ >10-fold. These
results suggest that Cak1 titration causes the deleterious effects due to expression of
unphosphorylatable Cdc28 in the cdc28CST mutants.

Maintenance of Cdc28:Cak1 ratio is crucial for normal growth in wild type cells

In the course of these studies we noticed that wild type cells consistently exhibited low
transformation efficiencies with single-copy plasmids harboring either CDC28 or cdc28-T169A. The
number of colonies for these transformations was 3- to 5- fold lower than in the empty vector
controls. We found that the lower transformation efficiencies were suppressed by high copy numbers
of CAK1 or cak1-KD (Fig. 11). This result suggests that maintenance of an optimum Cdc28:Cak1
ratio is required to support active cell growth. Cdc28 complexes are stable and exhibit highest CDK
activity only in the presence of optimum Cak1 levels. Accordingly, alteration of this ratio by
increasing copy numbers of Cdc28 results in formation of unstable complexes because Cak1 levels
become limited. In these conditions, a competition then ensues between stable and unstable Cdc28
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Fig. 11. Wild type cells show a deleterious growth effect with a CEN plasmid carrying CDC28
or cdc28-T169A, but this effect is suppressed by increasing CAK1 or cak1-KD copy numbers.
Wild type cells were sequentially transformed as indicated in Fig. 10
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for activators such as cyclins and/or Cks1, causing an overall lowering of CDK activity and thus
affecting growth rates and viability.

To further investigate the effect of altering the Cdc28:Cak1 ratio, we implemented a strategy that
combines use of inducible promoters and a cak1 mutant that exhibits low Cak1 protein levels: To
overexpress Cdc28 and Cak1, we used the inducible GAL1 promoter and its weaker derivative GALS
(20). To estimate the protein levels achieved when using these promoters, we transformed wild type
cells with plasmids that allow overexpression of Cdc28 under the control of the GAL1 or GALS
promoter (pGAL1>CDC28 or pGALS>CDC28). The respective transformants were grown overnight
in raffinose and treated with galactose for 6 hours. Protein extracts were prepared and analyzed by
western blotting using an anti-PSTAIRE antibody (Fig. 12). Under these conditions, we estimated
that the Cdc28 levels were at least two times higher when using the GAL1 promoter (quantified by
Image J soft program).

For these studies, we also included the cak1-23 mutant, which exhibits significantly lower Cak1
protein levels than the wild type strain at both permissive and restrictive temperatures (Fig. 13). Wild
type and cak1-23 strains were grown overnight at room temperature and then shifted to 34 °C.
Aliquots were taken at the indicated times, and protein extracts prepared and analyzed by western
blotting using a monoclonal anti-Cak1 antibody. To confirm equal loading, the membrane was
stripped and treated with an anti-Adh1 antibody (Adh1 is constitutively expressed and is one of five
alcohol dehydrogenases in yeast (28)).

To examine the effect of overexpressing Cdc28 in a regulated manner, we compare growth rates
of wild type and cak1-23 expressing varying levels of Cdc28 (Fig. 14). We transformed the strains
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Fig. 12. Overexpression of Cdc28 using the GAL1 and GALS promoters in wild type cells.
Levels of Cdc28 protein were determined by Western blot analysis using an anti-PSTAIRE antibody.
Immediately after transfer, membranes were stained using the “MemCode” reagent (Pierce) to
confirm equal loading and uniform and complete transfer. The molecular weight of Cdc28 is 34 kDa.
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Fig. 13. Lower Cak1 levels in the cak1-23 mutant at both permissive and restrictive
temperatures. Overnight cultures at 25 °C of wild type and cak1-23 were shifted to 34 °C and
aliquots taken at the indicated times. Protein extracts were prepared and loaded onto 10% SDSPAGE gels. The separated proteins were transferred to nitrocellulose membranes which were stained
reversibly first, and then processed for sequential Western analysis with anti-Cak1 and anti-Adh1
antibodies. The molecular weight of Cak1 is 44 kDa and that of Adh1 is 36 kDa.
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Glucose

Galactose

pGAL1>CDC28

Wild type
pGALS>CDC28
Empty vector

cak1-23

pGAL1>CDC28
pGALS>CDC28

Fig. 14. Overexpression of Cdc28 is deleterious in the cak1-23 mutant. Wild type and cak1-23
transformants harboring the indicated plasmids were grown under non-repressive conditions for the
GAL1 and GALS promoters, until saturation. The saturated cultures were serially diluted and aliquots
from each of the dilutions spotted on selective media containing glucose (promoter OFF) or galactose
(promoter ON). Plates were incubated at 25 °C for 2 - 3 days.
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with plasmids harboring no insert, pGAL1>CDC28, or pGALS>CDC28. The transformants were
grown to saturation in raffinose, serially diluted (2-fold) and 5-µl aliquots were spotted on either
glucose- or galactose- containing media. Plates were incubated at 25 °C. While the effect in wild type
cells was minimal, the cak1-23 mutant was extremely sensitive to overexpression of Cdc28, in a
dosage dependent manner (note the lower growth in cells transformed with pGAL1>CDC28).

We next investigated whether high copy numbers of the non-complementing cak1-KD allele
suppress the deleterious effect caused by overexpression of Cdc28 in cak1-23. We co-transformed
cak1-23 cells with the 2µ URA3 plasmid harboring cak1-KD, and either empty LEU2 vector control
or pGALS>CDC28 (Fig. 15). Transformants harboring the indicated plasmids were grown to
saturation in raffinose-containing media lacking leucine and uracil. To examine growth rates,
saturated cultures were serially diluted (3-fold) and aliquots spotted on the indicated media
containing either glucose or galactose. Plates were incubated at 23 °C or 30 °C. We found that
increasing copy numbers of cak1-KD using the 2µ plasmid resulted in minor suppression (evident
only at the permissive temperature 23 °C). The increase in copy numbers is limited by the replication
of the 2µ plasmid (up to ~60 – 100 copies) and under these conditions, expression of Cak1-KD
causes no obvious effect on growth of cak1-23 (top panel). We suspected that the higher expression
levels that can be achieved with the GAL promoters (up to ~200 fold) might cause a dominant
negative effect. We tested this possibility and as shown in the lower panel, overexpression of cak1KD using the GAL1 promoter shows a clear deleterious effect even at 25 °C.

Therefore, we cannot rule out a compound effect in these cells that prevent the observation of a
suppressing effect due to increased numbers of cak1-KD in cak1-23 cells overexpressing Cdc28.
Clarification of this issue will need the isolation of cak1 mutants that are not able to bind to Cdc28,
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Fig. 15. Compound effect in cak1-23 overexpressing Cdc28 and/or cak1-KD. cak1-23 cells were
transformed with the indicated plasmids and the respective transformants grown in selective media
containing raffinose. Saturated cultures were serially diluted and aliquots from each dilution spotted
on media lacking leucine and uracil and containing either glucose or galactose. Plates were incubated
for 2 – 3 days at the indicated temperatures.
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which will allow us to study independently the catalytic and binding roles of Cak1.

Cak1 is subjected to proteolysis when cells cease dividing

Kaldis et al. reported that Cak1 is stable in actively growing cells, but becomes unstable when
cells enter stationary phase (22). To learn more about how Cak1 levels are regulated, we follow Cak1
protein levels in wild type cells growing in rich media for up to 48 hours. These preliminary studies
showed that Cak1 levels decrease dramatically after cells reach an OD600nm >4.0, and Western blot
analysis also revealed bands of smaller size that showed increasing intensity as the time course
progressed.

To confirm these results, we used wild type cells expressing GST or a GST-Cak1 fusion under the
control of the GAL1 promoter (tag at the amino terminus). Cells were grown overnight in selective
media containing raffinose, cultures were diluted to OD600nm 0.3, and galactose added to 2% (“0”)
(Fig. 16). Aliquots were taken at the indicated times. Cak1 levels were determined by Western
blotting using both anti-Cak1 and anti-GST antibodies. GST-Cak1 levels clearly show a decrease
between the 9 h and 23 h time points. To check the possibility of non-specific proteolysis of Cak1,
we used cells lacking PEP4, one of the major vacuole proteases (21) and prepare the protein extracts
under denaturing conditions. Under these conditions, we observed a decrease in Cak1 protein levels
from the 15 hour time point, as growth in both cultures started slowing down and reaching a plateau
in growth rates (Fig. 17).
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Fig. 16. Cak1 is subjected to proteolytic degradation as cells cease dividing. Aliquots were taken
at the indicated times from asynchronous cultures of cells expressing GST-Cak1 under the control of
the GAL1 promoter (“0”, time at which galactose was added to start induction of expression). The
different panels show the results of sequential Western blot analyses of the same membrane with the
indicated antibodies. The molecular weight of GST-Cak1 is 68 kDa but in our system, the fusion
protein consistently migrates below our 62 kDa marker (identity confirmed with both monoclonal
and polyclonal antibodies).
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Fig. 17. Cak1 protein levels decrease when cells reach stationary phase.
pep4::kanMX6 cells transformed with empty vector or pGAL1>GST-CAK1 were grown in selective
media containing 2% galactose. Aliquots were taken at the indicated times. (a) Extracts containing 50
or 10 µg of total proteins were separated by SDS-PAGE and analyzed by Western blotting using
monoclonal anti-GST antibody. (b) Growth rates were inferred measuring OD600nm at each time point.
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CHAPTER IV-Discussion
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In previous work, our laboratory identified a number of cyclin-dependent kinase cdc28 mutants
defective in mitotic regulation that accordingly, exhibit sensitivity to microtubule inhibitors and
chromosome loss. Several of the mutations were found to localize to the carboxyl terminus of Cdc28
(residues Arg287 and Arg288), which led us to undertake further studies of this region. The carboxyl
termini of CDKs are highly conserved but had not been previously implicated in any essential
function. Mutations in the last 12 amino acids of Cdc28 were found to cause temperature sensitivity
and high chromosome instability. Six cdc28CST alleles were isolated and characterized. These data
suggested an essential role for the carboxyl terminus of Cdc28 during mitotic progression.
Importantly, it was subsequently found that high-copy Cak1 suppressed both the temperature
sensitivity and chromosome instability defects in the cdc28CST mutants, independently of Cak1’s
kinase activity.

In recent studies, we found that the cdc28CST mutants are extremely dependent on Cak1 dosage
and integrity. When cdc28CST mutants are transformed with plasmids harboring cdc28-T169A, an
unphosphorylatable allele, transformation efficiencies dramatically decrease (Fig. 9). Furthermore,
the cdc28CST mutants become inviable when the wild type Cak1 allele is substituted with one that is
temperature sensitive or modified with the addition of carboxy-terminal epitope tags. These results
support a model in which Cak1 not only phosphorylates Cdc28 but also interacts with its carboxyl
terminus, functioning as an assembly factor that promotes stabilization of the Cdc28 complexes.

Importantly, our results also indicate that actively growing yeast cells require maintenance of an
optimum Cdc28:Cak1 ratio. Increasing CDC28 gene copy numbers by one or two, via transformation
with a low copy plasmid harboring CDC28, causes low transformation efficiency in wild type cells
(Fig. 11). The expression and activity of Cak1 remains constant throughout the mitotic cell cycle;
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however, Kaldis et al. have found that Cak1 levels decrease when cells enter stationary phase (22).
Yeast cells arrest at G1 phase when nutrients, including ammonia, sulfate, and carbon sources are
depleted (3). Sustain arrest due to nutrient depletion causes entry into stationary phase, which allows
cells to maintain viability for extended periods and resume growth when appropriate nutrients are
added (42). Our studies confirmed that GST-Cak1 protein levels decrease when cells cease dividing
and enter into stationary phase, using both monoclonal anti-GST and polyclonal anti-Cak1 antibodies
(Figs. 16-17). While the particular sensitivities and specificities of the antibodies made the analysis
cumbersome (different intensities in some of the bands), analysis with both antibodies revealed a
very good correlation between growth rates and GST-Cak1 protein levels.

Heideman et al. reported that Cdc28 levels also decrease when nutrients become depleted, but
cells rapidly start producing Cdc28 when transferred into rich medium (31). Accordingly, we
hypothesize that Cak1 binds to Cdc28 to ensure presence of high CDK activities when cells sense
optimum nutrient conditions and are actively growing. When nutrients become depleted and cells
reach stationary phase, the stability of Cak1 decreases probably due to a specific proteolytic
mechanism. Under these unfavorable conditions for growth, lowering of Cak1 levels results in
instability and inactivation of Cdc28 complexes, and stalling of cell-cycle progression.

Working model:
Studies on the respective human homologues have indicated a Kd of 48 nM for the Cdk2-cyclin A
binding (19), and 1.5 μM for that of Cdk2 and Cks1 (35). On the other hand, the laboratories of Erin
O’Shea and Jonathan Weissman performed a global analysis of protein localization in yeast that
involved the construction of protein fusions with a tandem-affinity purification tag. Their studies

39

included quantitative Western blot analyses that determine the number of molecules per cell of a
large fraction of the yeast proteome, in actively growing cells (http:// yeastgfp.ucsf.edu) (15).
Taking into consideration the binding affinities and copy numbers of each Cdc28, the Cks1 activator,
the major mitotic cyclin Clb2, and Cak1, we propose that Cdc28 is sequentially activated as indicated
in Fig. 18. Given that Cak1 exhibits kinase activity throughout the cell cycle, residue Thr169 in
Cdc28 is constitutively phosphorylated: (I) Cdc28 and Cks1 bind with high affinity and are both
present in high copy numbers that remain constant in actively growing cells (6670 and 8780,
respectively). (II) Since cyclins are present in significantly lower numbers (339 for Clb2), for short
periods of time, and only at specific cell cycle stages, their association to Cdc28~Cks1 occur in a
subsequent step. The Cdc28~Cks1~Clb2 complex exhibits high activity but lacks stability. (III)
Stabilization of the complex is achieved via Cak1 binding, which ensures maintenance of high CDK
activity. (IV) Nutrient depletion forces cells to stop cell-cycle progression and enter stationary
phase: Degradation of Cak1 occurs first, and the lowering of Cak1 levels results in instability of the
Cdc28 complexes. Because at least Cak1, Cdc28 and cyclins are degraded, this step is irreversible
and therefore, de novo expression of Cdc28, Cak1, and cyclin subunits are required to resume cell
proliferation.
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Fig. 18. Working model: In a role that is separated from phosphorylation of Cdc28, Cak1
functions as an assembly factor that maintains Cdc28 complexes stable in actively growing cells.
See text for details.
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